Articles by Shahin Akhondzadeh

Pexacerfont as a CRF1 antagonist for the treatment of withdrawal symptoms in men with heroin/methamphetamine dependence: a randomized, double-blind, placebo-controlled clinical...

Morabbi, Mohammad-Javad; Razaghi, Emran; Moazen-Zadeh, Ehsan; More

International Clinical Psychopharmacology. ., Post Author Corrections: October 23, 2017